# US 2003/0229303 A1 · Expandable glaucoma implant and methods of use

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2003/0229303 A1
- Document ID: US20030229303A1
- Status: Published application
- Kind: A1
- Application number: 10/395,646
- Filed: 2003-03-21
- Published: 2003-12-11
- Earliest claimed: 2002-03-22
- Inventors: David S. Haffner; Gregory T. Smedley; Thomas W. Burns; Robert D. Anello; Hosheng Tu
- Web page: https://patentgrep.com/patent/US20030229303A1

## CPC

- A61F 9/00781: {Apparatus for modifying intraocular pressure, e.g. for glaucoma treatment (drainage implants in general A61M27/002)}
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)

## Abstract

Disclosed is an implant for use in an eye with glaucoma, the implant including an inlet section in fluid communication with an outlet section, the inlet section being sized and shaped to fit at least partially in the anterior chamber of the eye, and the outlet section being sized and shaped to fit at least partially in Schlemm's canal of the eye. The implant also includes an expandable substrate suitable for expansion in the eye to assist in retaining the implant in the eye.

## Claims

### Claim 1

An implant for use in an eye with glaucoma, said implant comprising:
an inlet section in fluid communication with an outlet section, said inlet section being sized and shaped to fit at least partially in the anterior chamber of said eye, and said outlet section being sized and shaped to fit at least partially in Schlemm's canal of said eye;
wherein said implant comprises a substrate that is expandable in the eye to assist in retaining the implant in the eye.

### Claim 2 (depends on 1)

The implant of claim 1, wherein the substrate is at the inlet section.

### Claim 3 (depends on 1)

The implant of claim 1, wherein the substrate is at the outlet section.

### Claim 4 (depends on 1)

The implant of claim 1, wherein a coating on the inlet and/or outlet sections comprises the expandable substrate.

### Claim 5 (depends on 1)

The implant of claim 1, wherein said implant comprises a material selected from the group consisting of titanium, stainless steel, silicone, polyurethane, polyvinyl alcohol, polyvinyl pyrolidone, collagen, heparinized collagen, polytetrafluoroethylene, expanded polytetrafluoroethylene, fluorinated polymer, fluorinated elastomer, flexible fused silica, polyolefin, polyester, and polysilicon.

### Claim 6 (depends on 1)

The implant of claim 1, wherein said implant comprises a biodegradable material selected from the group consisting of poly(lactic acid), polyethylene-vinyl acetate, poly(lactic-co-glycolic acid), poly(D,L-lactide), poly(D,L-lactide-co-trimethylene carbonate), poly(caprolactone), and poly(glycolic acid).

### Claim 7 (depends on 1)

The implant of claim 1, wherein the expandable substrate comprises a hydrogel.

### Claim 8 (depends on 7)

The implant of claim 7, wherein the hydrogel is hydrolytically degradable.

### Claim 9 (depends on 1)

The implant of claim 1, further comprising at least one therapeutic agent selected from the group consisting of heparin, beta-adrenergic antagonists, TGF-beta, anti-glaucoma drugs, and antibiotics.

### Claim 10 (depends on 1)

The implant of claim 1, further comprising at least one therapeutic agent selected from the group consisting of a gene, a growth factor, and an enzyme.

### Claim 11 (depends on 1)

The implant of claim 1, wherein said implant is substantially axisymmetric.

### Claim 12

A surgical method treating glaucoma in an eye comprising:
incising through the sclera of the eye and into Schlemm's canal of the eye;
placing an implant, having an inlet section in fluid communication with an outlet section, through said scleral incision into the eye such that the inlet section of the implant resides at least partially in the anterior chamber of the eye, and the outlet section resides at least partially in Schlemm's canal of said eye; and
expanding a substrate on the implant to assist in retaining the implant in the eye.

### Claim 13 (depends on 12)

The method of claim 12, wherein said substrate comprises a hydrogel.

### Claim 14

A surgical method treating glaucoma in an eye comprising:
incising through the cornea of the eye;
placing an implant, having an inlet section in fluid communication with an outlet section, through said corneal incision into the anterior chamber of the eye;
positioning the implant such that the inlet section of the implant resides at least partially in the anterior chamber of the eye, and the outlet section resides at least partially in Schlemm's canal of said eye; and
expanding a substrate on the implant to assist in retaining the implant in the eye.

### Claim 15 (depends on 14)

The method of claim 14, wherein said substrate comprises a hydrogel.
